https://www.healthbulletinhaiti.com/article/909983104-northeast-ohio-medical-university-neomed-celebrates-306-new-graduates-at-commencement-ceremony Health Bulletin Haiti en PressRelease 2026-05-02T22:07:03+00:00 Northeast Ohio Medical University (NEOMED) Celebrates 306 New Graduates at Commencement Ceremony https://ml.globenewswire.com/media/MDgwNDNmM2ItZGZiNi00NTRjLTgzZTUtMDg3MjZjNjY0NGIyLTUwMDE1MDkxOS0yMDI2LTA1LTAyLWVu/tiny/Northeast-Ohio-Medical-Univers.png https://www.healthbulletinhaiti.com/article/909978301-memopryl-gets-reviewed-complete-formula-evaluation-of-ingredient-claims-and-side-effects-risk Health Bulletin Haiti en PressRelease 2026-05-02T21:25:47+00:00 MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk https://zingfast.com/wp-content/uploads/2026/05/MemoPryl-Reviews.jpg https://www.healthbulletinhaiti.com/article/909972974-visiocore-claims-evaluated-the-8-second-amazonian-morning-flush-for-crystal-clear-vision-support Health Bulletin Haiti en PressRelease 2026-05-02T20:50:28+00:00 VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support https://zingfast.com/wp-content/uploads/2026/05/VisioCore-Supplement.jpg https://www.healthbulletinhaiti.com/article/909966566-halo-care-skin-tag-remover-claims-evaluated-the-strongest-most-effective-mole-skin-tag-corrector-serum Health Bulletin Haiti en PressRelease 2026-05-02T20:14:38+00:00 Halo Care Skin Tag Remover Claims Evaluated: The Strongest, Most Effective Mole & Skin Tag Corrector Serum https://zingfast.com/wp-content/uploads/2026/05/Halo-Care-Skin-Tag-Remover.jpg https://www.healthbulletinhaiti.com/article/909933274-milken-institute-global-conference-2026-set-to-open-tomorrow-in-beverly-hills-with-kfsh-participation Health Bulletin Haiti en PressRelease 2026-05-02T16:00:00+00:00 Milken Institute Global Conference 2026 Set to Open Tomorrow in Beverly Hills with KFSH Participation https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthbulletinhaiti.com/article/909933276-la-milken-institute-global-conference-2026-se-inaugura-ma-ana-en-beverly-hills-con-la-participaci-n-de-kfsh Health Bulletin Haiti en PressRelease 2026-05-02T16:00:00+00:00 La Milken Institute Global Conference 2026 se inaugura mañana en Beverly Hills con la participación de KFSH https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthbulletinhaiti.com/article/909933282-tem-in-cio-amanh-em-beverly-hills-a-milken-institute-global-conference-2026-com-a-participa-o-do-kfsh Health Bulletin Haiti en PressRelease 2026-05-02T16:00:00+00:00 Tem Início Amanhã em Beverly Hills a Milken Institute Global Conference 2026 com a Participação do KFSH https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthbulletinhaiti.com/article/909797332-avicanna-announces-change-in-board-of-directors Health Bulletin Haiti en PressRelease 2026-05-02T00:46:30+00:00 Avicanna Announces Change in Board of Directors https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://www.healthbulletinhaiti.com/article/909766133-pennant-acquires-senior-living-communities-in-arizona-and-wisconsin Health Bulletin Haiti en PressRelease 2026-05-01T22:28:47+00:00 Pennant Acquires Senior Living Communities in Arizona and Wisconsin https://ml.globenewswire.com/media/d50f543c-fc54-437d-8007-600644587dfe/small/pennant-logo-png.png https://www.healthbulletinhaiti.com/article/909766101-qu-ocurre-despu-s-del-avance-en-kfsh-la-innovaci-n-se-mide-por-la-repetici-n Health Bulletin Haiti en PressRelease 2026-05-01T22:06:55+00:00 Qué ocurre después del avance: En KFSH, la innovación se mide por la repetición https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthbulletinhaiti.com/article/909766148-o-que-acontece-depois-do-grande-avan-o-no-kfsh-a-inova-o-medida-pela-repeti-o Health Bulletin Haiti en PressRelease 2026-05-01T22:06:55+00:00 O Que Acontece Depois do Grande Avanço: No KFSH, a Inovação é Medida pela Repetição https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthbulletinhaiti.com/article/909752737-zentalis-pharmaceuticals-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T21:30:00+00:00 Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://www.healthbulletinhaiti.com/article/909752702-eupraxia-pharmaceuticals-appoints-dr-jeymi-tambiah-as-chief-medical-officer Health Bulletin Haiti en PressRelease 2026-05-01T21:05:06+00:00 Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.healthbulletinhaiti.com/article/909752698-celcuity-s-phase-3-viktoria-1-trial-achieves-primary-endpoint-with-clinically-meaningful-improvement-in-progression-free-survival-in-pik3ca-mutant Health Bulletin Haiti en PressRelease 2026-05-01T21:03:22+00:00 Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort https://ml.globenewswire.com/media/dab74495-313f-47dd-a6cb-b42a7f024edd/small/celcuity-logo-rgb-jpg.jpg https://www.healthbulletinhaiti.com/article/909746112-newamsterdam-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:57:13+00:00 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/f7b8b881-9461-4712-9965-707ed3bdd573/small/newamsterdam-logo-full-color-final-png.png https://www.healthbulletinhaiti.com/article/909746100-refills-glp-1-weight-loss-claims-evaluated-the-most-affordable-personalized-semaglutide-tirzepatide-glp1-program-with-online-doctor-support Health Bulletin Haiti en PressRelease 2026-05-01T20:54:10+00:00 Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support https://zingfast.com/wp-content/uploads/2026/05/Refills-GLP-1-Weight-Loss.jpg https://www.healthbulletinhaiti.com/article/909746056-equillium-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:42:32+00:00 Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://www.healthbulletinhaiti.com/article/909738830-oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:30:00+00:00 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png https://www.healthbulletinhaiti.com/article/909738963-celularity-announces-filing-of-form-10-k-regains-nasdaq-compliance-and-highlights-continued-strategic-transformation Health Bulletin Haiti en PressRelease 2026-05-01T20:30:00+00:00 Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation https://ml.globenewswire.com/media/NjdlZDZmZTAtM2Q4ZS00MWYzLWJhMzQtODEzMDk1YjI0OWNlLTEyMTY1NjItMjAyNi0wNS0wMS1lbg==/tiny/Celularity-Inc-.png https://www.healthbulletinhaiti.com/article/909739278-dianthus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:30:00+00:00 Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/c9002285-2240-4dab-aced-77296f86a3fa/small/dianthus-logo-primary-full-color-cmyk-png.png https://www.healthbulletinhaiti.com/article/909739339-spyre-therapeutics-announces-grants-of-inducement-awards Health Bulletin Haiti en PressRelease 2026-05-01T20:28:07+00:00 Spyre Therapeutics Announces Grants of Inducement Awards https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.healthbulletinhaiti.com/article/909738773-inspiremd-announces-fda-approval-of-investigational-device-exemption-application-for-cguardians-iii-pivotal-study-of-the-switchguard-neuro-protection Health Bulletin Haiti en PressRelease 2026-05-01T20:05:00+00:00 InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System https://ml-eu.globenewswire.com/media/5aefda10-5578-41c7-a1c0-9c4b700687c0/small/inspiremd-jpg.jpg https://www.healthbulletinhaiti.com/article/909738775-inspiremd-initiates-voluntary-u-s-recall-of-cguard-prime-135-cm-carotid-stent-delivery-system Health Bulletin Haiti en PressRelease 2026-05-01T20:05:00+00:00 InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System https://ml-eu.globenewswire.com/media/5aefda10-5578-41c7-a1c0-9c4b700687c0/small/inspiremd-jpg.jpg https://www.healthbulletinhaiti.com/article/909738791-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:05:00+00:00 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://www.healthbulletinhaiti.com/article/909738836-solid-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:05:00+00:00 Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://www.healthbulletinhaiti.com/article/909738914-candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:05:00+00:00 Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.healthbulletinhaiti.com/article/909739139-fate-therapeutics-reports-new-employee-inducement-award-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:05:00+00:00 Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.healthbulletinhaiti.com/article/909732246-xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:01:00+00:00 Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://www.healthbulletinhaiti.com/article/909732252-intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-01T20:01:00+00:00 Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.healthbulletinhaiti.com/article/909732282-avalyn-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares Health Bulletin Haiti en PressRelease 2026-05-01T20:01:00+00:00 Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.healthbulletinhaiti.com/article/909732349-tstrive-review-a-new-balanced-look-at-the-men-s-vitality-and-energy-supplement Health Bulletin Haiti en PressRelease 2026-05-01T20:00:44+00:00 Tstrive Review: A New Balanced Look at the Men’s Vitality and Energy Supplement https://ml.globenewswire.com/media/8d72a214-ab22-406c-8b1b-348acd2d4a85/small/555-jpg.jpg https://www.healthbulletinhaiti.com/article/909732300-derma-essential-claims-evaluated-investigating-the-ingredients-inside-dermaessential-healthy-skin-support-formula Health Bulletin Haiti en PressRelease 2026-05-01T19:47:17+00:00 Derma Essential Claims Evaluated: Investigating the Ingredients Inside DermaEssential Healthy Skin Support Formula https://zingfast.com/wp-content/uploads/2026/05/Derma-Essential.jpg https://www.healthbulletinhaiti.com/article/909725422-gala-glp-1-weight-loss-claims-evaluated-the-most-trusted-glp1-tirzepetide-telehealth-prescription-treatment-tracker-provider Health Bulletin Haiti en PressRelease 2026-05-01T19:17:18+00:00 Gala GLP-1 Weight Loss Claims Evaluated: The Most Trusted GLP1 Tirzepetide Telehealth Prescription Treatment & Tracker Provider https://zingfast.com/wp-content/uploads/2026/05/Gala-GLP-1-Weight-Loss.jpg https://www.healthbulletinhaiti.com/article/909718727-what-happens-after-the-breakthrough-at-kfsh-innovation-is-measured-by-repetition Health Bulletin Haiti en PressRelease 2026-05-01T18:40:00+00:00 What Happens After the Breakthrough: At KFSH, Innovation Is Measured by Repetition https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthbulletinhaiti.com/article/909698748-human-garage-launches-global-28-day-reset-on-may-1-to-help-millions-release-stress-and-pain Health Bulletin Haiti en PressRelease 2026-05-01T17:26:46+00:00 Human Garage launches Global 28-Day Reset on May 1 to help millions release stress and pain https://ml.globenewswire.com/media/8955d53b-9b2b-4fa6-ade8-e86efec4b87b/small/unnamed-jpg.jpg https://www.healthbulletinhaiti.com/article/909687364-arvinas-announces-fda-approval-of-veppanu-vepdegestrant-for-the-treatment-of-esr1m-er-her2-advanced-breast-cancer Health Bulletin Haiti en PressRelease 2026-05-01T16:43:18+00:00 Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://www.healthbulletinhaiti.com/article/909687295-confluent-medical-technologies-names-tom-testa-as-chief-operating-officer Health Bulletin Haiti en PressRelease 2026-05-01T16:30:18+00:00 Confluent Medical Technologies Names Tom Testa as Chief Operating Officer https://ml.globenewswire.com/media/e39458f8-b884-4738-b1f0-5dd6046a9d4e/medium/tom-testa-coo.JPG https://www.healthbulletinhaiti.com/article/909682353-rezolute-announces-oral-presentation-of-results-from-its-phase-3-sunrize-study-of-ersodetug-in-patients-with-congenital-hyperinsulinism-at-the Health Bulletin Haiti en PressRelease 2026-05-01T16:15:00+00:00 Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting https://ml.globenewswire.com/media/d26d1af6-0969-4bba-b973-6d2294367aae/medium/figure-1.PNG https://www.healthbulletinhaiti.com/article/909671323-hyperion-defi-schedules-first-quarter-earnings-call-for-thursday-may-14-at-8-00-a-m-et Health Bulletin Haiti en PressRelease 2026-05-01T15:12:40+00:00 Hyperion DeFi Schedules First Quarter Earnings Call for Thursday, May 14 at 8:00 a.m. ET https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg